Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-16 · accession 0001831410-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-18 | 2025-09-16+ | OLMA | Harmon Cyrus | Dir | S - Sale | $8.19 | -20.0K | 744.1K | -3% | -$163.7K |
| MI | 2025-09-18 | 2025-09-16+ | OLMA | Harmon Cyrus | Dir | S - Sale | $8.23 | -5,000 | 120.1K | -4% | -$41.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | S | D | 10,000 | $8.04 | 754,140 | D | — | — | (F1) The weighted average sale price for the transaction reported was $8.04, and the range of prices was between $8.02 and $8.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-09-18 | S | D | 10,000 | $8.33 | 744,140 | D | — | — | (F2) The weighted average sale price for the transaction reported was $8.33, and the range of prices was between $8.28 and $8.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2025-09-18 | S | D | 3,086 | $8.32 | 117,028 | I See Footnote | — | — | (F5) The weighted average sale price for the transaction reported was $8.32, and the range of prices was between $8.29 and $8.33. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. (F4) The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager. |
| 4 | Common | Common Stock | 2025-09-16 | S | D | 1,914 | $8.08 | 120,114 | I See Footnote | — | — | (F3) The weighted average sale price for the transaction reported was $8.08, and the range of prices was between $8.04 and $8.08. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. (F4) The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager. |